Research graph
References from CORN 2.0 - Condition Orientated Regulatory Networks 2.0. Local targets link to admitted publications; unresolved targets remain external evidence.
Effect of genistein intake on some cardiovascular risk factors: an updated systematic review and meta-analysis
10.1016/j.cpcardiol.2021.100902 · 2022 · External reference
10.1038/s41573-020-00114-z
10.1038/s41573-020-00114-z · External reference
10.1016/j.canlet.2008.03.052
10.1016/j.canlet.2008.03.052 · External reference
10.1093/nar/gks1193
10.1093/nar/gks1193 · External reference
10.1039/c3np70058e
10.1039/c3np70058e · External reference
Pharmacological targeting of guanosine monophosphate synthase suppresses melanoma cell invasion and tumorigenicity
10.1038/cdd.2015.47 · 2015 · External reference
10.1093/nar/gkac1077
10.1093/nar/gkac1077 · External reference
10.1002/stem.1365
10.1002/stem.1365 · External reference
Roles for MYC in the establishment and maintenance of pluripotency
10.1101/cshperspect.a014381 · 2013 · External reference
10.1038/s41580-018-0010-5
10.1038/s41580-018-0010-5 · External reference
Bioprinting 3D human induced pluripotent stem cell constructs for multilineage tissue engineering and modeling
10.1007/978-1-0716-0520-2_17 · 2020 · External reference
10.1002/mrd.23559
10.1002/mrd.23559 · External reference
NELFE-dependent MYC signature identifies a unique cancer subtype in hepatocellular carcinoma
10.1038/s41598-019-39727-9 · 2019 · External reference
Natural product derived privileged scaffolds in drug discovery
10.1016/j.cbpa.2018.12.007 · 2019 · External reference
10.1002/jcb.26356
10.1002/jcb.26356 · External reference
Crowdsourcing natural products discovery to access uncharted dimensions of fungal metabolite diversity
10.1002/anie.201306549 · 2014 · External reference
Epigenetic modification of histone 3 lysine 27: mediator subunit MED25 is required for the dissociation of polycomb repressive complex 2 from the promoter of cytochrome P450 2C9
10.1074/jbc.m114.579474 · 2015 · External reference
GRNdb: decoding the gene regulatory networks in diverse human and mouse conditions
10.1093/nar/gkaa995 · 2021 · External reference
Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia
1992 · External reference
Romidepsin: a new drug for the treatment of cutaneous T-cell lymphoma
10.1188/12.cjon.195-204 · 2012 · External reference
Preclinical activity of the oral proteasome inhibitor MLN9708 in Myeloma bone disease
10.1158/1078-0432.ccr-13-1657 · 2014 · External reference
Long-term exposure to genistein inhibits the proliferation of gallbladder cancer by downregulating the MCM complex
10.1016/j.scib.2022.01.011 · 2022 · External reference
Decoding molecular markers and transcriptional circuitry of naive and primed states of human pluripotency
10.1016/j.scr.2021.102334 · 2021 · External reference
Genistein: A Review on its Anti-Inflammatory Properties
10.3389/fphar.2022.820969 · 2022 · External reference
10.1038/s41586-022-04593-5
10.1038/s41586-022-04593-5 · External reference
HMGB2 holds the key to the senescence-associated secretory phenotype
10.1083/jcb.201610044 · 2016 · External reference
10.1126/sciadv.aba1972
10.1126/sciadv.aba1972 · External reference
10.1093/nar/gkab996
10.1093/nar/gkab996 · External reference
10.1016/j.cell.2010.10.008
10.1016/j.cell.2010.10.008 · External reference
Selumetinib: a selective MEK1 inhibitor for solid tumor treatment
10.1007/s10238-021-00783-z · 2023 · External reference
10.1016/j.isci.2022.105889
10.1016/j.isci.2022.105889 · External reference
10.1126/science.1239278
10.1126/science.1239278 · External reference
10.1016/j.csbj.2020.06.033 · Admitted local publication
10.1093/nar/gkw1092
10.1093/nar/gkw1092 · External reference
10.1007/s10295-015-1723-5
10.1007/s10295-015-1723-5 · External reference
10.1093/nar/gky1033
10.1093/nar/gky1033 · External reference
The art of using t-SNE for single-cell transcriptomics
10.1038/s41467-019-13056-x · 2019 · External reference
10.1038/s41592-019-0619-0
10.1038/s41592-019-0619-0 · External reference
10.1038/s41591-018-0096-5
10.1038/s41591-018-0096-5 · External reference
Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study
10.1007/s00394-012-0304-x · 2013 · External reference
Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries
10.1021/cc000097l · 2001 · External reference
ENPD - a database of eukaryotic nucleic acid binding proteins: linking gene regulations to proteins
10.1093/nar/gky1112 · 2019 · External reference
CORN-Condition Orientated Regulatory Networks: bridging conditions to gene networks
2022 · External reference
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?
2017 · External reference
10.1101/gad.1903310
10.1101/gad.1903310 · External reference
Cellular prion protein transcriptionally regulated by NFIL3 enhances lung cancer cell lamellipodium formation and migration through JNK signaling
10.1038/s41388-019-0994-0 · 2020 · External reference
10.1038/s41586-020-2734-6
10.1038/s41586-020-2734-6 · External reference
RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse
2015 · External reference
10.1016/j.freeradbiomed.2022.03.021
10.1016/j.freeradbiomed.2022.03.021 · External reference
10.1016/j.cell.2017.01.018
10.1016/j.cell.2017.01.018 · External reference
10.1038/s41590-023-01522-0
10.1038/s41590-023-01522-0 · External reference
Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer
10.1007/978-3-030-24100-1_2 · 2019 · External reference
HMGB2 regulates the differentiation and stemness of exhausted CD8(+) T cells during chronic viral infection and cancer
10.1038/s41467-023-41352-0 · 2023 · External reference
10.1021/acs.jnatprod.9b01285
10.1021/acs.jnatprod.9b01285 · External reference
10.1101/cshperspect.a008128
10.1101/cshperspect.a008128 · External reference
10.1126/science.1254257
10.1126/science.1254257 · External reference
10.1038/s41422-019-0195-y
10.1038/s41422-019-0195-y · External reference
10.1038/s41422-020-0355-0
10.1038/s41422-020-0355-0 · External reference
Cell fate conversion prediction by group sparse optimization method utilizing single-cell and bulk OMICs data
2021 · External reference
Bortezomib: proteasome inhibition as an effective anticancer therapy
10.1146/annurev.med.57.042905.122625 · 2006 · External reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · External reference
10.1038/nbt.3192
10.1038/nbt.3192 · External reference
10.1002/stem.1384
10.1002/stem.1384 · External reference
Med25 Limits Master Regulators That Govern Adipogenesis
10.3390/ijms24076155 · 2023 · External reference
10.1165/rcmb.2018-0416tr
10.1165/rcmb.2018-0416tr · External reference
10.1038/s41467-017-02391-6
10.1038/s41467-017-02391-6 · External reference
10.1038/s41568-022-00500-2
10.1038/s41568-022-00500-2 · External reference
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis
10.1038/ncomms10869 · 2016 · External reference
Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits
10.1155/2021/3268136 · 2021 · External reference
Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease
10.3233/jad-2008-13207 · 2008 · External reference
Midostaurin the First Targeted Therapy to Improve Survival in AML: Potentially Practice-Changing
2016 · External reference
10.1016/j.cell.2017.10.049
10.1016/j.cell.2017.10.049 · External reference
10.3322/caac.21660
10.3322/caac.21660 · External reference
Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris
10.1038/s41586-018-0590-4 · 2018 · External reference
10.1038/nature13173
10.1038/nature13173 · External reference
10.1093/nar/gkac1052
10.1093/nar/gkac1052 · External reference
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
10.1038/ja.2011.35 · 2011 · External reference
DNA- and RNA-Binding Proteins Linked Transcriptional Control and Alternative Splicing Together in a Two-Layer Regulatory Network System of Chronic Myeloid Leukemia
10.3389/fmolb.2022.920492 · 2022 · External reference
10.1038/nprot.2013.150
10.1038/nprot.2013.150 · External reference
Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia
10.1200/jco.1985.3.5.617 · 1985 · External reference
10.1038/nrm.2015.28
10.1038/nrm.2015.28 · External reference
Why people use herbal medicine: insights from a focus-group study in Germany
10.1186/s12906-018-2160-6 · 2018 · External reference
The Potential of Stem Cells in Treatment of Traumatic Brain Injury
10.1007/s11910-018-0812-z · 2018 · External reference
Functional analysis of two Sp1/Sp3 binding sites in murine Nanog gene promoter
10.1038/sj.cr.7310040 · 2006 · External reference
10.1016/j.xinn.2021.100141
10.1016/j.xinn.2021.100141 · External reference
HAG (Homoharringtonine, Cytarabine, G-CSF) Regimen for the Treatment of Acute Myeloid Leukemia and Myelodysplastic Syndrome: A Meta-Analysis with 2,314 Participants
10.1371/journal.pone.0164238 · 2016 · External reference
10.18632/aging.204896
10.18632/aging.204896 · External reference
10.1093/bioinformatics/btu684
10.1093/bioinformatics/btu684 · External reference
10.1093/nar/gky1094
10.1093/nar/gky1094 · External reference
10.1016/j.molcel.2018.03.030
10.1016/j.molcel.2018.03.030 · External reference
